- Lobbying
- spark AND therapeutics
Lobbying Arrangements Results for 'Spark Therapeutics'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details H.R. 2666 - MVP Act, all provisions. Issues related to the Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program Notice for Propos... |
SPARK THERAPEUTICS, INC.
|
in-house lobbying | |||
Details Issues related to healthcare reform and PDUFA/FDA authorization. |
Spark Therapeutics, Inc.
|
MONUMENT POLICY GROUP, LLC | |||
Details Education regarding gene therapies/one-time treatments; policies and regulations impacting drugs for rare diseases and conditions; FDA modernization Value-based pricing arrangements; MVP Act - HR 2666 |
Spark Therapeutics, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to the development of gene therapies for rare diseases |
Spark Therapeutics, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to Health Care. |
Spark Therapeutics
|
Harbinger Strategies, LLC |